Sohomoy
Bone Metastasis Market: Revolutionizing Bone-Modifying Biologics, Radioligand Therapies, and Oncology Workflows
Surging global incidence of advanced solid tumors such as breast, prostate, and lung cancers prone to skeletal dissemination, expanding geriatric populations vulnerable to skeletal-related events (SREs) like pathologic fractures and spinal cord compression, and continuous biopharmaceutical innovations in bisphosphonates, RANK ligand inhibitors, and targeted radiopharmaceuticals are driving...
5 Views